BUECHLER KENNETH F 4
4 · QuidelOrtho Corp · Filed Jun 2, 2026
Research Summary
AI-generated summary of this filing
QuidelOrtho Director Kenneth Buechler Receives 6,829 Shares
What Happened
Kenneth F. Buechler, a director of QuidelOrtho Corporation (QDEL), had 6,829 restricted stock units vest on May 29, 2026 and those units were converted into 6,829 shares. The Form 4 reports the acquisition and the conversion at $0.00 per share (the filing shows a non-cash award/vesting event, not an open-market purchase or sale).
Key Details
- Transaction date: May 29, 2026.
- Reported entries: Award/Grant (A) — 6,829 shares @ $0.00 (acquired); Exercise/conversion of derivative (M) — 6,829 shares @ $0.00 (derivative conversion).
- Footnotes: F1 = release of previously reported RSUs; F2 = each RSU equals one share; F3 = RSUs vested on May 29, 2026.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Filing: Form 4 filed June 2, 2026 — within the SEC’s two-business-day reporting window for the May 29 transaction (timely).
Context
This was a routine vesting and conversion of previously granted restricted stock units into common shares (M = conversion of derivative; A = acquired shares). The $0.00 amounts reflect the mechanics of the award conversion in the Form 4, not the market value of the shares. Such vesting events are common compensation for directors and do not, by themselves, indicate a buy or sell signal from the insider.
Insider Transaction Report
- Award
Common Stock
[F1]2026-05-29+6,829→ 108,750 total - Exercise/Conversion
Restricted Stock Units (Equity Grant)
[F2][F3]2026-05-29−6,829→ 0 total→ Common Stock (6,829 underlying)
Footnotes (3)
- [F1]Reflects release of restricted stock units that were previously reported on a Form 4.
- [F2]Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
- [F3]The restricted stock units vested on May 29, 2026.